LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.39 | 770.25 | 3905 | 9326 | 0.4187 | 0.5702 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 63.39 | 770.25 | 4076 | 9326 | 0.4371 | 0.5890 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.61 | 770.25 | 4087 | 9736 | 0.4198 | 0.5777 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 65.61 | 770.25 | 4280 | 9736 | 0.4396 | 0.5977 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.83 | 770.25 | 4268 | 10078 | 0.4235 | 0.5865 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 67.83 | 770.25 | 4494 | 10078 | 0.4459 | 0.6087 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.05 | 770.25 | 4463 | 10413 | 0.4286 | 0.5962 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 70.05 | 770.25 | 4635 | 10413 | 0.4451 | 0.6123 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.27 | 770.25 | 4593 | 10730 | 0.4280 | 0.5998 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 72.27 | 770.25 | 4806 | 10730 | 0.4479 | 0.6190 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.50 | 770.25 | 4767 | 10991 | 0.4337 | 0.6085 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 74.50 | 770.25 | 5090 | 10991 | 0.4631 | 0.6362 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.75 | 770.25 | 5012 | 11262 | 0.4450 | 0.6224 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 76.75 | 770.25 | 5318 | 11262 | 0.4722 | 0.6475 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.98 | 770.25 | 5228 | 11518 | 0.4539 | 0.6335 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 78.98 | 770.25 | 5602 | 11518 | 0.4864 | 0.6627 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 81.20 | 770.25 | 5456 | 11766 | 0.4637 | 0.6450 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 81.20 | 770.25 | 5801 | 11766 | 0.4930 | 0.6709 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 83.42 | 770.25 | 5688 | 12031 | 0.4727 | 0.6557 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 83.42 | 770.25 | 6056 | 12031 | 0.5033 | 0.6821 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 85.64 | 770.25 | 5860 | 12287 | 0.4769 | 0.6617 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 85.64 | 770.25 | 6391 | 12287 | 0.5201 | 0.6982 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.86 | 770.25 | 6103 | 12543 | 0.4866 | 0.6723 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 87.86 | 770.25 | 6692 | 12543 | 0.5335 | 0.7110 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 3.21 | 770.25 | 786 | 904 | 0.8689 | 0.0912 | MN20160304_L02 | G10 |